maralixibat (as maralixibat chloride 10 MG/ML) 9.5 MG/ML Oral Solution

RxCUI: 2571079
RxNorm name: maralixibat (as maralixibat chloride 10 MG/ML) 9.5 MG/ML Oral Solution
Display name: maralixibat (as maralixibat chloride 10 MG/ML) 9.5 MG/ML Oral Solution
Full name: maralixibat (as maralixibat chloride 10 MG/ML) 9.5 MG/ML Oral Solution
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Livmarli	MARALIXIBAT CHLORIDE	Mirum Pharmaceuticals Inc.	64000394-1ef6-4e76-8ba8-11f25ba1b167	2025-04-10	Warnings, Adverse reactions	Exact identifier rxcui: 2571079

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
64000394-1ef6-4e76-8ba8-11f25ba1b167	maralixibat (as maralixibat chloride 10 MG/ML) 9.5 MG/ML Oral Solution	SY	11	These highlights do not include all the information needed to use LIVMARLI safely and effectively. See full prescribing information for LIVMARLI. LIVMARLI ® (maralixibat) oral solution LIVMARLI ® (maralixibat) tablets, for oral use Initial U.S. Approval: 2021	20250410
64000394-1ef6-4e76-8ba8-11f25ba1b167	maralixibat 9.5 MG/mL Oral Solution	PSN	11	These highlights do not include all the information needed to use LIVMARLI safely and effectively. See full prescribing information for LIVMARLI. LIVMARLI ® (maralixibat) oral solution LIVMARLI ® (maralixibat) tablets, for oral use Initial U.S. Approval: 2021	20250410
64000394-1ef6-4e76-8ba8-11f25ba1b167	maralixibat 9.5 MG/ML Oral Solution	SCD	11	These highlights do not include all the information needed to use LIVMARLI safely and effectively. See full prescribing information for LIVMARLI. LIVMARLI ® (maralixibat) oral solution LIVMARLI ® (maralixibat) tablets, for oral use Initial U.S. Approval: 2021	20250410